E-viri
Recenzirano
-
Menicagli, V; Barbanera, M; Menicagli, S
Recenti progressi in medicina 82, Številka: 2Journal Article
In order to evaluate the antibody response to anti-hepatitis B vaccine, 21 heroin addicted with HIV infection previously vaccinated, were studied. 18 patients were asymptomatic and 3 were at the LAS stage. An antibody response was estimated at 1 and 12 months after the end of the vaccination. The first control showed that 62% presented a protective anti-HBs (higher than 10 mU/ml); after one year 70% of responders had a persistent immunity. The antibody response showed no correlation with the value of immunologic tests; the vaccine showed neither a significant evidence of side-effects nor a negative influence on the HIV infection.
